The effects of PAI‐1 on TSA‐induced ESCC cell migration, morphological changes, and EMT markers were also studied by administrating the PAI‐1 inhibitor PAI‐039. The gene discussed is SERPINE1; the disease is esophageal squamous cell carcinoma.